Citation Impact
Citing Papers
Salt-Sensitive Blood Pressure in Mice With Increased Expression of Aldosterone Synthase
2007 StandoutNobel
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
New concepts in vascular nitric oxide signaling
2000
The PPARα Activator Fenofibrate Slows Down the Progression of the Left Ventricular Dysfunction in Porcine Tachycardia-Induced Cardiomyopathy
2007
Role of Oxidative-Nitrosative Stress and Downstream Pathways in Various Forms of Cardiomyopathy and Heart Failure
2005
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?
2003
Low-frequency blood flow oscillations in congestive heart failure and after β1-blockade treatment
2008
β3-Adrenoceptors in the cardiovascular system
2000
Acute and Chronic Endothelial Dysfunction: Implications for the Development of Heart Failure
2003
Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity.
1997 Standout
Skeletal Muscle Fatigue: Cellular Mechanisms
2008 Standout
Dynamic 123I‐BMIPP single‐photon emission computed tomography in patients with congestive heart failure: Effect of angiotensin ii type‐1 receptor blockade
2004
AMPK: guardian of metabolism and mitochondrial homeostasis
2017 Standout
Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
2008 Standout
Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure
2005
gp91phox-containing NAD(P)H oxidase mediates attenuation of nitric oxide-dependent control of myocardial oxygen consumption by ANG II
2005
Oxidant activity in skeletal muscle fibers is influenced by temperature, CO2level, and muscle-derived nitric oxide
2004
The Failing Heart — An Engine Out of Fuel
2007 Standout
Angiotensin II hypertension is attenuated in interleukin-6 knockout mice
2005
Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure
2002
Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects
2006
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
2005 Standout
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure☆
2004
Ultrathin conformal devices for precise and continuous thermal characterization of human skin
2013 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Mitochondria, nitric oxide, and cardiovascular dysfunction
2002
Myocardial Contractile Effects of Nitric Oxide
2002
Combined inhibition of nitric oxide and prostaglandins reduces human skeletal muscle blood flow during exercise
2002
Paracrine and autocrine effects of nitric oxide on myocardial function
2000
Energy Metabolism in the Normal and Failing Heart: Potential for Therapeutic Interventions
2002
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Nitric oxide inhibits cardiac energy production via inhibition of mitochondrial creatine kinase
1999
Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression
2002
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Regulation of Coronary Blood Flow During Exercise
2008
Physiologically Tolerable Insulin Reduces Myocardial Injury and Improves Cardiac Functional Recovery in Myocardial Ischemic/Reperfused Dogs
2006
Hemodynamic effects of inducible nitric oxide synthase and nitrotyrosine generation in heart failure
2004
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
2004
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation
2004
Angiotensin-converting enzyme inhibition improves cardiac fatty acid metabolism in patients with congestive heart failure
2003
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Diabetes and Atherosclerosis
2002 Standout
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
2004 Standout
Pacemaker implantation and quality of life in the Mode Selection Trial (MOST)
2006
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary
2008
Chronic Activation of Peroxisome Proliferator-Activated Receptor-α with Fenofibrate Prevents Alterations in Cardiac Metabolic Phenotype without Changing the Onset of Decompensation in Pacing-Induced Heart Failure
2007
Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy
2007
Control of cytochrome c oxidase activity by nitric oxide
2003
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
2013 Standout
Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production
2008 Standout
Ventricular Pacing or Dual-Chamber Pacing for Sinus-Node Dysfunction
2002
Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure
2008
Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle
2004
Role of nitric oxide in coronary arterial vasomotion and the influence of coronary atherosclerosis and its risks
1998
Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase
2001
Is nitric oxide overproduction the target of choice for the management of septic shock?
2001
Biomarkers in Heart Failure
2008 Standout
Palmitate-mediated Alterations in the Fatty Acid Metabolism of Rat Neonatal Cardiac Myocytes
2000
Nitric oxide as a regulator of tissue oxygen consumption
1999
Nitric oxide controls cardiac substrate utilization in the conscious dog
1999
Effects of nitric oxide on the contraction of skeletal muscle
1999
Effects of supplemental oxygen administration on coronary blood flow in patients undergoing cardiac catheterization
2005
Catecholamine stimulation is associated with impaired myocardial O2 utilization in heart failure
2002
Fatty acid metabolism assessed by 125I‐iodophenyl 9‐methylpentadecanoic acid (9MPA) and expression of fatty acid utilization enzymes in volume‐overloaded hearts
2004
Superior Cardiovascular Effect of Aerobic Interval Training Versus Moderate Continuous Training in Heart Failure Patients
2007 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs
2002
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Endothelial Nitric Oxide Synthase in Vascular Disease
2006 Standout
Exercise training in chronic heart failure: correlation between reduced local inflammation and improved oxidative capacity in the skeletal muscle
2005
Smoking a Single Cigarette Rapidly Reduces Combined Concentrations of Nitrate and Nitrite and Concentrations of Antioxidants in Plasma
2002
Copper Active Sites in Biology
2014 Standout
Regulation of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) and mitochondrial function by MEF2 and HDAC5
2003
Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
2002 StandoutNobel
Nuclear Receptor Signaling and Cardiac Energetics
2004
Is Dual-Chamber Programming Inferior to Single-Chamber Programming in an Implantable Cardioverter-Defibrillator?
2006
Oxidative Stress–Mediated Cardiac Cell Death Is a Major Determinant of Ventricular Dysfunction and Failure in Dog Dilated Cardiomyopathy
2001
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Role of Nitric Oxide in the Regulation of Substrate Metabolism in Heart Failure
2002
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
How mitochondria produce reactive oxygen species
2008 Standout
Reduced Gene Expression of Vascular Endothelial NO Synthase and Cyclooxygenase-1 in Heart Failure
1996
Novel Molecular Mechanism of Increased Myocardial Endothelin-1 Expression in the Failing Heart Involving the Transcriptional Factor Hypoxia-Inducible Factor-1α Induced for Impaired Myocardial Energy Metabolism
2001
Inhibition of Rat Cardiac Muscle Contraction and Mitochondrial Respiration by Endogenous Peroxynitrite Formation During Posthypoxic Reoxygenation
1998
Metabolomic Profiling Reveals Distinct Patterns of Myocardial Substrate Use in Humans With Coronary Artery Disease or Left Ventricular Dysfunction During Surgical Ischemia/Reperfusion
2009
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Cardiac-Specific Overexpression of Inducible Nitric Oxide Synthase Does Not Result in Severe Cardiac Dysfunction
2002
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
Concentration-dependent effects of bradykinin on leukocyte recruitment and venular hemodynamics in rat mesentery
1999
Mechanisms for Increased Glycolysis in the Hypertrophied Rat Heart
2004
NITRIC OXIDE AND MACROPHAGE FUNCTION
1997 Standout
Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block
2000
Endothelial nitric oxide synthase plays an essential role in regulation of renal oxygen consumption by NO
2001
Exercise Training Increases Basal Nitric Oxide Production From the Forearm in Hypercholesterolemic Patients
1999
Nitric Oxide and Cardiac Function
2003
Heart Failure During Cardiac Pacing
2006
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
The Role of Nitric Oxide in the Failing Heart
2001
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke
2003
Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity
2003
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
PDE5 Inhibition With Sildenafil Improves Left Ventricular Diastolic Function, Cardiac Geometry, and Clinical Status in Patients With Stable Systolic Heart Failure
2010
Nitric oxide partitioning into mitochondrial membranes and the control of respiration at cytochrome c oxidase
2001
Effect of Simvastatin and Antioxidant Vitamins on Atrial Fibrillation Promotion by Atrial-Tachycardia Remodeling in Dogs
2004
The PDZ-binding motif of the β 2 -adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes
2003 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Nitric Oxide Modulates Myocardial Oxygen Consumption in the Failing Heart
2002
Impaired Myocardial Fatty Acid Oxidation and Reduced Protein Expression of Retinoid X Receptor-α in Pacing-Induced Heart Failure
2002
NAD(P)H oxidase-generated superoxide anion accounts for reduced control of myocardial O2consumption by NO in old Fischer 344 rats
2003
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
2004 Standout
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Myocardial Glucose Uptake Is Regulated by Nitric Oxide via Endothelial Nitric Oxide Synthase in Langendorff Mouse Heart
2000
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Creatine and Creatinine Metabolism
2000 Standout
Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression.
1996
Endothelial Function and Dysfunction
2007 Standout
Works of Robert Bernstein being referenced
Kinin-Mediated Coronary Nitric Oxide Production Contributes to the Therapeutic Action of Angiotensin-Converting Enzyme and Neutral Endopeptidase Inhibitors and Amlodipine in the Treatment in Heart Failure
1999
Nitric oxide and oxygen utilization
1999
The Mode Selection Trial (MOST) in sinus node dysfunction: Design, rationale, and baseline characteristics of the first 1000 patients
2000
Endogenous nitric oxide in the control of skeletal muscle oxygen extraction during exercise
2000
Mechanisms of Nitrate Accumulation in Plasma during Pacing-Induced Heart Failure in Conscious Dogs
1997
Cytokines Are Not a Requisite Part of the Pathophysiology Leading to Cardiac Decompensation
2000
Selective Impairment of Vagally Mediated, Nitric Oxide–Dependent Coronary Vasodilation in Conscious Dogs After Pacing-Induced Heart Failure
1995
Simvastatin upregulates coronary vascular endothelial nitric oxide production in conscious dogs
2000
Relationship between plasma NOx and cardiac and vascular dysfunction after LPS injection in anesthetized dogs
1998
Reduced NO-dependent arteriolar dilation during the development of cardiomyopathy
2000
Pharmacodynamics of Plasma Nitrate/Nitrite as an Indication of Nitric Oxide Formation in Conscious Dogs
1995
Nitric Oxide Modulates Mitochondrial Respiration in Failing Human Heart
1999
Reduced Nitric Oxide Production and Altered Myocardial Metabolism During the Decompensation of Pacing-Induced Heart Failure in the Conscious Dog
1998
Function and Production of Nitric Oxide in the Coronary Circulation of the Conscious Dog During Exercise
1996